Our expertise research and development spans the entire life-cycle of a medicine. We have capabilities in both small molecules and biologics. This allows us to search for solutions to unmet medical needs using both modalities, individually or in combination
Horizon Discovery & AstraZeneca: Searching for novel, personalised cancer therapies
An IMED Collaboration Update
At AstraZeneca, our bold ambition is to transform the lives of people with cancer and one day help to eliminate cancer as a cause of death. A joint project plan agreed with Horizon Discovery, a Cambridge, UK-based translational genomics company, is ensuring that innovation is at the forefront of our collaboration. Our partnership uses cutting-edge science to develop advanced approaches to the treatment of cancer through a better understanding of the genetic basis of the disease.
All Directors are collectively responsible for the success of AstraZeneca. Discover general information, images and biographies of our Board of Directors.
AstraZeneca's pipeline is one of the most exciting in the industry. Download the latest version of our development pipeline.
Path to new medicines
The discovery, development and commercialisation of a medicine is a complex process. Information on our path to new medicines and an interactive overview are available.
Visit our dedicated neuroscience site for more information on our research and partnering in the area.
Visit our Open Innovation site to see how we collaborate to push the boundaries of science and deliver life-changing medicines